Liver Diseases: Extracellular Vesicles as Biomarkers

NANot yet recruitingINTERVENTIONAL
Enrollment

845

Participants

Timeline

Start Date

September 22, 2025

Primary Completion Date

December 1, 2027

Study Completion Date

March 31, 2028

Conditions
Liver Diseases
Interventions
OTHER

blood sampling for volunteers

A 38.5 ml blood sample will be taken to test for research taken to test for research

OTHER

blood sampling for diabetics patients with F3/F4 fibrosis

32.5 ml will be sampled at inclusion, at one year visit and two year visit

OTHER

blood sampling for patients with liver disease

A blood sample of 35.5 mL maximum will be taken for research purposes at the inclusion visit, M1 visit and M3 visit.

Trial Locations (1)

Unknown

Bichat Hospital, Beaujon Hospital, Cochin Hospital and Lariboisière Hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT07185360 - Liver Diseases: Extracellular Vesicles as Biomarkers | Biotech Hunter | Biotech Hunter